On April 14, E Fund CSI 300 Pharmaceutical ETF (512010) closed up 0.29%, with a turnover of 491 million yuan.
Pharmaceutical ETF (512010) was established on September 23, 2013, and the full name of the fund is E Fund CSI 300 Medical and Health Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as E Fund CSI 300 Pharmaceutical ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the pharmaceutical ETF (512010) is based on the CSI 300 Medical and Health Index.
In terms of scale, as of April 11, the latest share of pharmaceutical ETF (512010) was 63.065 billion shares, and the latest scale was 21.940 billion yuan. Looking back on December 31, 2024, the share of pharmaceutical ETF (512010) was 64.168 billion shares, with a scale of 23.120 billion yuan. That is, the share of the fund has decreased by 1.72% and the scale has decreased by 5.10% since the beginning of this year.
In terms of liquidity, as of April 14, the cumulative turnover of pharmaceutical ETF (512010) in the past 20 trading days was 14.024 billion yuan, with an average daily turnover of 701 million yuan, and since the beginning of this year, the cumulative turnover in 66 trading days has been 42.564 billion yuan, with an average daily turnover of 645 million yuan.
The current fund manager of the Pharmaceutical ETF (512010) is Yu Haiyan. Yu Haiyan has managed (or intends to manage) the fund since September 23, 2013, with a return of 39.16% during her tenure.
According to the latest regular report, the heavy stocks of pharmaceutical ETF (512010) include Hengrui Pharmaceutical, Mindray Medical, WuXi AppTec, Pien Tze Huang, Aier Ophthalmology, Yunnan Baiyao, United Imaging Medical, Kelun Pharmaceutical, NHU and Shanghai RAAS, and the proportion of holdings is as follows.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600276 | Hengrui Pharmaceutical | : 16.36%, | 82.3979 thousand | , 3.782 billion |
| , 300760 | ,Mindray Medical | , 12.35%, | 11.1958 million | , 2.855 billion |
| 603259 | WuXi AppTec | 10.98% | 46.1382 trillion | 2.539 billion |
| 600436 | Pien Tze Huang | 5.17% | 5.5713 trillion | 1.195 billion |
| 300015 | Aier Ophthalmology | 4.93% | 86.0327 million | 1.140 billion |
| 000538 | Yunnan Baiyao | 4.27% | 16.4783 million | 988 million |
| 688271 | United Imaging Medical | 4.16%, | 7.6145 million, | 962 million |
| 002422 | Kelun Pharmaceutical | , 3.06%, | 23.6525 million | , 708 million |
| 002001 | Xinhecheng | 2.71% | 28.4986 million | 626 million |
| 002252 | Shanghai RAAS | 2.68% | 85.8693 trillion | 620 million |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
